Enzyme system in diabetes
Bremer, J.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 90(2): 203-207
1970
ISSN/ISBN: 0029-2001 PMID: 5430188 Document Number: 26239
Document emailed within 1 workday
Related Documents
Matthews, P.G.; Johnston, C.I. 1979: Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225) Advances in Experimental Medicine and Biology 120b: 447-457Kondo, K.; Kida, O.; Kodama, K.; Higa, T.; Someya, N.; Morotomi, Y.; Tanaka, K. 1985: Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system Nihon Jinzo Gakkai Shi 27(3): 337-342
Marre, M. 1992: Converting enzyme inhibitors in diabetes La Revue du Praticien 42(20): 2574-2577
Murthy, A.S.; Baquer, N.Z. 1983: Changes in malic enzyme in brain during alloxan diabetes Indian Journal of Biochemistry and Biophysics 20(1): 53-55
Sobczak, M.; Wilczyński, J.; Cypryk, K.; Woch, G. 1999: Bacterial flora in infections of the urinary system system in pregnant women with pre-gestational diabetes Ginekologia Polska 70(10): 725-731
Geller, L.I.; Pribylova, N.F. 1971: Pancreatic enzyme activity in different biological media of diabetes mellitus patients Problemy Endokrinologii 17(6): 31-34
Polunin, G.S.; Andzhelova, D.V.; Kiseleva, T.N. 2004: The enzyme therapy within a complex treatment of hemophthalmos in patients with diabetes mellitus Vestnik Oftalmologii 120(5): 14-16
Rakhimov, K.R.; Zaripov, B.Z. 1978: Effect of alloxan diabetes on the enzyme activity of the mucous membrane of the small intestine Problemy Endokrinologii 24(6): 85-89
Wu, H.; Qu, S.; Zhang, Y.; Deng, J.; Li, J.; Zhou, J. 2000: The changes of serum angiotensin converting enzyme activity in Type 2 diabetes and its vascular complications Hua Xi Yi Ke da Xue Xue Bao 31(3): 373-375
Nowakowski, T.K.; Sassowa, J.; Wasikowa, R. 1970: Blood enzyme studies in the evaluation of liver function in juvenile diabetes mellitus Pediatria Polska 45(4): 407-412
Szabó, J.; Fodor, E.; Vetési, F.; Tenk, I. 1981: Pancreatic and small-intestinal digestive enzyme activities in rats with streptozotocin-diabetes Acta Veterinaria Academiae Scientiarum Hungaricae 29(4): 451-469
Dominguez, J.R.; de la Calle, H.; Hurtado, A.; Robles, R.G.; Sancho-Rof, J. 1986: Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus Postgraduate Medical Journal 62(Suppl 1): 66-68
Valentovic, M.A.; Elliott, C.W.; Ball, J.G. 1987: The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme activity Research Communications in Chemical Pathology and Pharmacology 58(1): 27-39
Winter, R.; Piskorska, D. 1980: Glyoxalase enzyme system Postepy Biochemii 26(3): 389-409
Engbaek, F.; Christensen, S.E.; Jespersen, B. 1989: Enzyme immunoassay of hemoglobin A1c: analytical characteristics and clinical performance for patients with diabetes mellitus, with and without uremia Clinical Chemistry 35(1): 93-97
Moleda, P.; Majkowska, L.; Safranow, K.; Goracy, I.; Adler, G. 2007: I/D polymorphism of angiotensin i converting enzyme gene and arterial hypertension in patients with type 2 diabetes mellitus Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 22(129): 169-172
Dotsenko, V.L.; Demidova, T.I.; Neshkova, E.A.; Ametov, A.S.; Iarovaia, G.A. 1998: Possible participation of angiotensin-converting enzyme and leukocyte elastase in the pathogenesis of insulin-independent diabetes mellitus Voprosy Meditsinskoi Khimii 44(2): 203-212
Nitiyanant, W.; Sriussadaporn, S.; Ploybutr, S.; Watanakejorn, P.; Tunlakit, M.; Bejrachandra, S. 1997: Angiotensin converting enzyme gene polymorphism in healthy Thais and patients with non-insulin dependent diabetes mellitus Journal of the Medical Association of Thailand 80(12): 747-752
Elorriaga-Sánchez, F.; Corrales-Bobadilla, H.; Sosa-Trinidad, E.; Domínguez-Quezada, B. 2001: Severe hypoglycemia secondary to angiotensin-converting-enzyme inhibitors in the absence of diabetes mellitus. Report of a case Gaceta Medica de Mexico 137(3): 249-252
Karagezian, K.G.; Vartanian, G.S.; Badalian, M.G. 1980: Changes in the phospholipid spectrum and activity of certain phosphatide-synthesis enzyme systems in the brain and liver of rats with alloxan diabetes Biulleten' Eksperimental'noi Biologii i Meditsiny 90(12): 679-681